| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $17.78B | $16.71B | $15.81B |
| YoY Revenue Growth % | +6.4% | +5.7% | — |
| Gross Profit | $9.17B | $8.55B | — |
| Gross Margin % | 51.6% | 51.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $3.46B | $3.25B | $3.19B |
| Operating Margin % | 19.5% | 19.5% | 20.2% |
| Net Income (GAAP) | $2.54B | $2.39B | $2.35B |
| EBITDA (Normalized) | $4.40B | $4.07B | $3.76B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.76B | $3.05B | $3.03B |
| Capital Expenditures (CapEx) | $1.17B | $1.02B | $711.6M |
| Free Cash Flow (FCF) | $1.59B | $2.03B | $2.32B |
| FCF Margin % | 9.0% | 12.1% | 14.7% |
| Return on Invested Capital (ROIC %) | 54.0% | 63.9% | 10.6% |
| Cash & Short-Term Equivalents | $193.8M | $130.2M | — |
| Total Debt (Short + Long Term) | $6.02B | $5.52B | $9.17B |
| Total Stockholders' Equity | -$763.4M | -$1.37B | $18.81B |